135 related articles for article (PubMed ID: 18421682)
1. Independent component analysis of dynamic contrast-enhanced magnetic resonance images of breast carcinoma: a feasibility study.
Koh TS; Thng CH; Ho JT; Tan PH; Rumpel H; Khoo JB
J Magn Reson Imaging; 2008 Jul; 28(1):271-7. PubMed ID: 18421682
[TBL] [Abstract][Full Text] [Related]
2. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
[TBL] [Abstract][Full Text] [Related]
5. A fuzzy c-means (FCM)-based approach for computerized segmentation of breast lesions in dynamic contrast-enhanced MR images.
Chen W; Giger ML; Bick U
Acad Radiol; 2006 Jan; 13(1):63-72. PubMed ID: 16399033
[TBL] [Abstract][Full Text] [Related]
6. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
Woods BJ; Clymer BD; Kurc T; Heverhagen JT; Stevens R; Orsdemir A; Bulan O; Knopp MV
J Magn Reson Imaging; 2007 Mar; 25(3):495-501. PubMed ID: 17279534
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis.
Heldahl MG; Bathen TF; Rydland J; Kvistad KA; Lundgren S; Gribbestad IS; Goa PE
Acta Radiol; 2010 Jul; 51(6):604-12. PubMed ID: 20429756
[TBL] [Abstract][Full Text] [Related]
8. Accelerated bilateral dynamic contrast-enhanced 3D spiral breast MRI using TSENSE.
Han M; Daniel BL; Hargreaves BA
J Magn Reson Imaging; 2008 Dec; 28(6):1425-34. PubMed ID: 19025951
[TBL] [Abstract][Full Text] [Related]
9. A wide variety of dynamic contrast-enhanced MR appearances of breast cancer: pathologic correlation study.
Onishi M; Furukawa A; Takahashi M; Murata K
Eur J Radiol; 2008 Feb; 65(2):286-92. PubMed ID: 17683886
[TBL] [Abstract][Full Text] [Related]
10. Calculation of intravascular signal in dynamic contrast enhanced-MRI using adaptive complex independent component analysis.
Mehrabian H; Chopra R; Martel AL
IEEE Trans Med Imaging; 2013 Apr; 32(4):699-710. PubMed ID: 23247848
[TBL] [Abstract][Full Text] [Related]
11. Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data.
Makkat S; Luypaert R; Sourbron S; Stadnik T; De Mey J
J Magn Reson Imaging; 2007 Jun; 25(6):1159-67. PubMed ID: 17520720
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging contrast-enhanced relaxometry of breast tumors: an MRI multicenter investigation concerning 100 patients.
Eliat PA; Dedieu V; Bertino C; Bouté V; Lacroix J; Constans JM; de Korvin B; Vincent C; Bailly C; Joffre F; de Certaines J; Vincensini D
Magn Reson Imaging; 2004 May; 22(4):475-81. PubMed ID: 15120166
[TBL] [Abstract][Full Text] [Related]
14. Independent component analysis of dynamic contrast-enhanced computed tomography images.
Koh TS; Yang X; Bisdas S; Lim CC
Phys Med Biol; 2006 Oct; 51(19):N339-48. PubMed ID: 16985265
[TBL] [Abstract][Full Text] [Related]
15. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.
Su MY; Baik HM; Yu HJ; Chen JH; Mehta RS; Nalcioglu O
Technol Cancer Res Treat; 2006 Aug; 5(4):401-10. PubMed ID: 16866570
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of benign phyllodes tumors of the breast.
Kinoshita T; Fukutomi T; Kubochi K
Breast J; 2004; 10(3):232-6. PubMed ID: 15125750
[TBL] [Abstract][Full Text] [Related]
17. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
[TBL] [Abstract][Full Text] [Related]
18. Interactive detection and visualization of breast lesions from dynamic contrast enhanced MRI volumes.
Subramanian KR; Brockway JP; Carruthers WB
Comput Med Imaging Graph; 2004 Dec; 28(8):435-44. PubMed ID: 15541950
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced breast MR imaging.
Moon M; Cornfeld D; Weinreb J
Magn Reson Imaging Clin N Am; 2009 May; 17(2):351-62. PubMed ID: 19406363
[TBL] [Abstract][Full Text] [Related]
20. Characterizing early contrast uptake of ductal carcinoma in situ with high temporal resolution dynamic contrast-enhanced MRI of the breast: a pilot study.
Jansen SA; Fan X; Medved M; Abe H; Shimauchi A; Yang C; Zamora M; Foxley S; Olopade OI; Karczmar GS; Newstead GM
Phys Med Biol; 2010 Oct; 55(19):N473-85. PubMed ID: 20858914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
